A pharmacokinetic study of telavancin in healthy male volunteers: A microdialysis study

Trial Profile

A pharmacokinetic study of telavancin in healthy male volunteers: A microdialysis study

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Jul 2016

At a glance

  • Drugs Telavancin (Primary)
  • Indications Gram-positive infections; Nosocomial pneumonia; Skin and soft tissue infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 27 Oct 2015 New trial record
    • 21 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top